Teacher Retirement System of Texas Decreases Stake in Certara, Inc. (NASDAQ:CERT)

Teacher Retirement System of Texas lowered its holdings in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 0.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,528,931 shares of the company's stock after selling 29,020 shares during the period. Teacher Retirement System of Texas owned about 2.80% of Certara worth $44,836,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its position in shares of Certara by 218.8% in the first quarter. Versant Capital Management Inc now owns 2,719 shares of the company's stock valued at $27,000 after purchasing an additional 1,866 shares during the last quarter. Wells Fargo & Company MN lifted its stake in Certara by 48.4% in the 4th quarter. Wells Fargo & Company MN now owns 3,208 shares of the company's stock valued at $34,000 after buying an additional 1,047 shares in the last quarter. Johnson Financial Group Inc. acquired a new stake in Certara during the 4th quarter valued at $47,000. ANTIPODES PARTNERS Ltd increased its position in Certara by 204.7% during the fourth quarter. ANTIPODES PARTNERS Ltd now owns 5,442 shares of the company's stock worth $58,000 after buying an additional 3,656 shares in the last quarter. Finally, Sterling Capital Management LLC raised its holdings in shares of Certara by 57.2% in the fourth quarter. Sterling Capital Management LLC now owns 7,209 shares of the company's stock worth $77,000 after acquiring an additional 2,624 shares during the last quarter. Institutional investors and hedge funds own 73.96% of the company's stock.

Analyst Ratings Changes

CERT has been the topic of a number of analyst reports. Robert W. Baird increased their price objective on Certara from $9.00 to $13.00 and gave the company a "neutral" rating in a research note on Friday, April 11th. KeyCorp raised their price target on shares of Certara from $15.00 to $18.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 16th. Barclays upgraded shares of Certara from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $11.00 to $14.00 in a report on Thursday, May 8th. JMP Securities reissued a "market perform" rating on shares of Certara in a research note on Tuesday, May 6th. Finally, Morgan Stanley initiated coverage on shares of Certara in a research note on Thursday. They issued an "equal weight" rating and a $16.00 target price for the company. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $15.71.

Certara Trading Down 1.4%

Shares of NASDAQ CERT traded down $0.16 on Friday, reaching $11.33. 1,281,456 shares of the company traded hands, compared to its average volume of 1,459,372. The stock has a market capitalization of $1.84 billion, a PE ratio of -566.50 and a beta of 1.43. Certara, Inc. has a fifty-two week low of $8.64 and a fifty-two week high of $16.93. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 0.27. The company has a 50 day moving average of $11.65 and a 200 day moving average of $11.86.

Certara (NASDAQ:CERT - Get Free Report) last issued its quarterly earnings results on Monday, May 5th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.10 by $0.04. The firm had revenue of $106.00 million during the quarter, compared to analyst estimates of $104.44 million. Certara had a negative net margin of 0.67% and a positive return on equity of 5.05%. Certara's revenue for the quarter was up 9.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.10 earnings per share. On average, equities research analysts forecast that Certara, Inc. will post 0.28 earnings per share for the current fiscal year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.